JSLCX | JTOIX | JSLCX / JTOIX | |
Total Expense Ratio | 1.08 | 0.93 | 116% |
Annual Report Gross Expense Ratio | 1.18 | 0.94 | 126% |
Fund Existence | 20 years | 10 years | - |
Gain YTD | -0.442 | -0.407 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.56B | 1.56B | 100% |
Annual Yield % from dividends | 4.02 | 4.17 | 97% |
Returns for 1 year | 5.82 | 5.97 | 98% |
Returns for 3 years | 5.05 | 5.50 | 92% |
Returns for 5 years | 11.01 | 11.89 | 93% |
Returns for 10 years | 15.54 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JSVZX | 20.76 | 0.23 | +1.12% |
JPMorgan Small Cap Value R2 | |||
ANOYX | 19.94 | 0.15 | +0.76% |
American Century Small Cap Growth Y | |||
VIGIX | 181.15 | 0.19 | +0.10% |
Vanguard Growth Index Institutional | |||
GCLLX | 14.41 | N/A | N/A |
Goldman Sachs Enh Core EqFund-ClassC | |||
HBGHX | 13.55 | -0.16 | -1.17% |
Hartford Healthcare HLS IB |